CalciMedica (CALC) Interest Expenses (2019 - 2026)
CalciMedica's (CALC) quarterly Interest Expenses came in at $319000.0 in Q1 2026, down 28.64% YoY from $447000.0 in Q1 2025, and down 1.85% on a QoQ basis from $325000.0 in Q4 2025.
CalciMedica (CALC) Interest Expenses (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Interest Expenses data on file, last reported at $319000.0 in Q1 2026.
- Quarterly Interest Expenses fell 28.64% year-over-year to $319000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 118.7% YoY) and the FY2025 annual result came in at $92.7 million, up 4.74% from the prior year.
- Interest Expenses retreated to $319000.0 in Q1 2026, from $325000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $3.1 million in Q3 2025 to a low of $41000.0 in Q3 2023.
- A 5-year average of $578375.0 and a median of $348000.0 in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses plunged 86.69% — and 2024, when it surged 3021.95%.
- Tracing CALC's Interest Expenses over 5 years: stood at $100000.0 in 2022, then dropped by 24.0% to $76000.0 in 2023, then surged by 1584.21% to $1.3 million in 2024, then sank by 74.61% to $325000.0 in 2025, then fell by 1.85% to $319000.0 in 2026.
- The last three Interest Expenses figures came in at $319000.0 (Q1 2026), $325000.0 (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | CalciMedica | 9.93 Mn | -8.69 Mn | - | 325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 325,000.00 |
| Jun 30, 2026 | 325,000.00 |
| Mar 31, 2026 | 319,000.00 |
| Mar 31, 2026 | 319,000.00 |
| Dec 31, 2025 | 325,000.00 |
| Dec 31, 2025 | 325,000.00 |
| Sep 30, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 324,000.00 |
| Jun 30, 2025 | 324,000.00 |
| Mar 31, 2025 | 447,000.00 |
| Mar 31, 2025 | 447,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Mar 31, 2024 | 790,000.00 |
| Mar 31, 2024 | 790,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Dec 31, 2023 | 76,000.00 |